It has been suggested that PAX1 methylation is associated with HPV16/18 infection in cervical cancer, which further influences the efficacy of radiotherapy by inducing the methylation of the PAX1 promoter in host cells (96) (Figure 5A). Here, PAX1 is linked to cervical cancer.